Lilly's Foundayo (orforglipron) significantly reduced obstructive sleep apnea severity, reinforcing its potential to improve health beyond weight loss
This newly indexed research record examines “Lilly's Foundayo (orforglipron) significantly reduced obstructive sleep apnea severity, reinforcing its potential to improve health beyond weight loss.” Use the linked PR Newswire publication to assess the study design, population, methods, findings and limitations; an indexed record alone should not be read as clinical guidance.
Open original source ↗Collected Nov 9, 2026. Third-party data may change. Consult the original publication or registry for complete methods, findings and status.